Eterna Therapeutics
ERNA
ERNA
20 hedge funds and large institutions have $1.19M invested in Eterna Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
77% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 22
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$387K | |
| 2 | +$304K | |
| 3 | +$23.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.75K |
| 5 |
Morgan Stanley
New York
|
+$2.22K |
Top Sellers
| 1 | -$604K | |
| 2 | -$274K | |
| 3 | -$207K | |
| 4 |
Renaissance Technologies
New York
|
-$177K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$49.2K |